Industry Verticals »

All Categories

Insights »

About TMR »

Antithrombin Market Forecast, 2019-2027

Antithrombin Market (Application - Therapeutics, Research, and Diagnostics; Source - Human, and Goat Milk; Dosage Form - Lyophilized and Liquid) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2019 - 2027

Rising Usage of Rapid Diagnostic Tests that Use Antithrombin Fuel Demand in Antithrombin Market

The rising incidence of various health conditions such as sepsis, disseminated intravascular coagulation or DIC, congenital antithrombin deficiency, and extracorporeal membrane oxygenation or ECMO is anticipated to boost the demand in the global antithrombin market in coming years. Another major driver for the global antithrombin market is the increasing demand and instances of elevated open heart surgeries. Products in the global antithrombin market are absolutely essential for the long term treatment of thrombotic diseases. This is positively influencing the sales as well as production of the antithrombin drugs in the global antithrombin market. Furthermore, rising usage of rapid diagnostic tests that use antithrombin are also triggering an increased need for solutions and protein molecules in the global antithrombin market.

However, rising utilization of biologics as well as high cost associated with antithrombin are two of the key challenges for the growth of the global antithrombin market in coming years. Solutions in the global antithrombin market replicate the antithrombin protein created by the liver in human body. This protein aids in reducing the clotting of the blood by inactivating the thrombin compounds. Products in the global antithrombin market are used in various healthcare scenarios such as cardiac surgeries as well as in antithrombin deficiency disorders. Rising disposable incomes in emerging economies and adoption of new treatment procedures are also some of the major drivers for the global antithrombin market.

Furthermore, increase in the occurrence of venous thromboembolism or VTE is various western economies is fueling the demand in the global antithrombin market. Moreover, rising awareness pertaining to thrombotic diseases and its ill effects on human body such as liver failure, severe burns, and nephrotic syndrome, is also favoring the adoption of the remedies and solutions offered by the players and manufacturers in the global antithrombin market. Furthermore, increase in the usage of solutions in the global antithrombin market for various therapeutic process in the healthcare sector is also anticipated to positively impact the demand dynamics of the global antithrombin market in the next few years.

  • According to Transparency Market Research’s latest report on the global antithrombin treatment market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of hereditary antithrombin deficiency to escalate the growth of global antithrombin treatment market. Moreover, adoption of new therapeutics is projected to drive the global antithrombin treatment market during the forecast period
  • According to the report, the global antithrombin treatment market was valued at US$ 0.50 Bn in 2018 and is anticipated to expand at a CAGR of 5.3% from 2019 to 2027

Rise in Focus on Research & Rising Demand and Acceptance of Antithrombin Therapy: Key Drivers of Global Antithrombin Treatment Market

  • The acceptance of antithrombin in several medical conditions over conventional once is contribute to driving the demand for products and thereby drive the global antithrombin market.
  • Antithrombin is approved by FDA as anticoagulant and indicated in venous thromboembolic events in hereditary antithrombin deficient patients. Antithrombin also used in treatment of disseminated intravascular coagulation syndrome (DIC) and extracorporeal membrane oxygenation (ECMO), etc. Thus, gradual increase in prevalence of hereditary antithrombin deficiency leading to increase in the demand for the products and thereby drive the growth of market.
  • Key players are investing in research and development in order to develop new therapeutics to address the unmet needs. This in turn to drive the growth of the global antithrombin treatment market. For instance, China Biologic Products Holdings, Inc. integrated plasma-based biopharmaceutical company in China develop Human Antithrombin III for treatment of hereditary antithrombin III deficiency in connection with surgical or obstetrical procedures and thromboembolism is in clinical trial phase III.

Technological Advancements Propel Global Antithrombin Treatment Market Growth

  • Technological advancements have helped bring down the total costs involved in production of therapeutic proteins. This has encouraged suppliers and manufacturers to seek newer avenues of therapeutic protein manufacturing and also to deal with longer and complex chains of peptides. Technological advancements in antithrombin is likely to boost the growth of the market in the near future

Pricing Pressure to Hamper Global Antithrombin Treatment Market

  • Pricing is one of the concern over substitute and conventional anticoagulant therapy which could hamper growth of global antithrombin market. In many regions like Asia Pacific and Europe price concern hampers adoption of antithrombin therapy as there also pricing pressures, as antithrombin is seen as an expensive treatment with few returns.

Global Antithrombin Treatment Market: Competitive Landscape

  • This report profiles major players in the global antithrombin treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global antithrombin treatment market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global antithrombin treatment market are rEVO Biologics, Inc., Grifols, Shire plc., CSL Limited, Kedrion S.p.A, Octapharma AG, Dem ilac Inc., Lee Bisolutions, Diapharma, Scripps Laboratories, Inc. and Other Prominent Companies

Global Antithrombin Treatment Market: Key Developments

Key players in the global antithrombin treatment market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global antithrombin treatment market. A few expansion strategies adopted by players operating in the global antithrombin treatment market are:

  • In September 2017, Kyowa Hakko Kirin Co., Ltd. received approval for additional formulation, ACOALAN injection 1800 IU
  • In August 2017, CSL Limited completed transaction to acquire a majority stake in China-based plasma fractionator, Wuhan Zhong Yuan Rui De Biological Products Co. Ltd.
  • In July 2017, CSL Ltd. announced launch of Haegarda (subcutaneous C1-INH, CSL830) in the U.S. approved for the treatment of hereditary angioedema (HAE) in patients
  • In January 2016, Octapharma announced launch of Nuwiq used in hemophilia patients to control bleeding, perioperative (surgical) management, and routine prophylaxis, in adults and children with hemophilia  A

The report on the global antithrombin treatment market discussed individual strategies, followed by company profiles of manufacturers of antithrombin products. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global antithrombin treatment market.

Frequently Asked Questions

What is the total market worth of antithrombin market?

The global antithrombin market was worth US$ 0.50 Bn and is projected to reach a value of US$ 0.79 Bn by the end of 2027

What is the anticipated CAGR of antithrombin market in forecast period?

Antithrombin market is anticipated to grow at a CAGR of 5.3% during the forecast period

Which region is expected to project highest market share in antithrombin market?

North America accounted for a major share of the global antithrombin market

What are the key driving factors for growth of antithrombin market?

Antithrombin market is driven by rising incidence of various health conditions such as sepsis, disseminated intravascular coagulation or DIC, congenital antithrombin deficiency, and extracorporeal membrane oxygenation or ECMO is anticipated to boost the demand in the global market

Who are the key players in the global antithrombin market?

Key players in the global antithrombin market include rEVO Biologics, Inc., Grifols, Shire plc., CSL Limited, Kedrion S.p.A, Octapharma AG, Dem ilac Inc., Lee Bisolutions, Diapharma and Scripps Laboratories, Inc

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Antithrombin Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Application Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global  Antithrombin Treatment Market Analysis and Forecasts, 2017–2027

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis Globally: Snapshot

    5.3. Healthcare Industry Overview

6. Global Antithrombin Treatment Market Analysis and Forecasts, By Application

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        6.3.1. Therapeutic

        6.3.2. Research

        6.3.3. Diagnostics

    6.4. Global Antithrombin Treatment Market Attractiveness By Application

7. Global Antithrombin Treatment Market Analysis and Forecasts, By Source

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        7.3.1. Human

        7.3.2. Goat Milk

        7.3.3. Others (Bovine, etc.)

    7.4. Global Antithrombin Treatment Market Attractiveness By Source

8. Global  Antithrombin Treatment Analysis and Forecasts, By Dosage Form

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        8.3.1. Lyophilized

        8.3.2. Liquid

    8.4. Global Antithrombin Treatment Market Attractiveness By Dosage Form

9. Global Antithrombin Treatment Market Analysis and Forecasts, By Region

    9.1. Key Findings

    9.2. Global Antithrombin Treatment Market Value  Forecast By Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Antithrombin Treatment Market Attractiveness By Country/Region

10. North America Antithrombin Treatment Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America  Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        10.2.1. Therapeutic

        10.2.2. Research

        10.2.3. Diagnostics

    10.3. North America  Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        10.3.1. Human

        10.3.2. Goat Milk

        10.3.3. Others (Bovine, etc.)

    10.4. North America  Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        10.4.1. Lyophilized

        10.4.2. Liquid

    10.5. North America  Antithrombin Treatment Market Value  Forecast By Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America  Antithrombin Treatment Market Attractiveness Analysis

        10.6.1. By Application

        10.6.2. By Source

        10.6.3. By Dosage Form

        10.6.4. By Country

11. Europe Antithrombin Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        11.2.1. Therapeutic

        11.2.2. Research

        11.2.3. Diagnostics

    11.3. Europe Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        11.3.1. Human

        11.3.2. Goat Milk

        11.3.3. Others (Bovine, etc.)

    11.4. Europe Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        11.4.1. Lyophilized

        11.4.2. Liquid

    11.5. Europe Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Antithrombin Treatment Market Attractiveness Analysis

        11.6.1. By Application

        11.6.2. By Source

        11.6.3. By Dosage Form

        11.6.4. By Country/Sub-region

12. Asia Pacific Antithrombin Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        12.2.1. Therapeutic

        12.2.2. Research

        12.2.3. Diagnostics

    12.3. Asia Pacific Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        12.3.1. Human

        12.3.2. Goat Milk

        12.3.3. Others (Bovine, etc.)

    12.4. Asia Pacific Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        12.4.1. Lyophilized

        12.4.2. Liquid

    12.5. Asia Pacific Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Antithrombin Treatment Market Attractiveness Analysis

        12.6.1. By Application

        12.6.2. By Source

        12.6.3. By Dosage Form

        12.6.4. By Country/Sub-region

13. Latin America Antithrombin Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        13.2.1. Therapeutic

        13.2.2. Research

        13.2.3. Diagnostics

    13.3. Latin America Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        13.3.1. Human

        13.3.2. Goat Milk

        13.3.3. Others (Bovine, etc.)

    13.4. Latin America Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        13.4.1. Lyophilized

        13.4.2. Liquid

    13.5. Latin America Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Antithrombin Treatment Market Attractiveness Analysis

        13.6.1. By Application

        13.6.2. By Source

        13.6.3. By Dosage Form

        13.6.4. By Country/Sub-region

14. Middle East & Africa Antithrombin Treatment Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Application, 2017–2027

        14.2.1. Therapeutic

        14.2.2. Research

        14.2.3. Diagnostics

    14.3. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Source, 2017–2027

        14.3.1. Human

        14.3.2. Goat Milk

        14.3.3. Others (Bovine, etc.)

    14.4. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Dosage Form, 2017–2027

        14.4.1. Lyophilized

        14.4.2. Liquid

    14.5. Middle East & Africa Antithrombin Treatment Market Value  Forecast By Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Antithrombin Treatment Market Attractiveness Analysis

        14.6.1. By Application

        14.6.2. By Source

        14.6.3. By Dosage Form

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis/Ranking By Company (2018)

    15.3. Company Profiles

        15.3.1. rEVO Biologics, Inc.

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis.

        15.3.2. Grifols

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis.

        15.3.3. Shire plc.

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis.

        15.3.4. CSL Limited

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis.

        15.3.5. Kedrion S.p.A

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis.

        15.3.6. Octapharma AG

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis.

        15.3.7. Dem ilac Inc.

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis.

        15.3.8. Lee Bisolutions

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis.

        15.3.9. Diapharma

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Growth Strategies

            15.3.9.3. SWOT Analysis.

        15.3.10. Scripps Laboratories, Inc.

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Growth Strategies

            15.3.10.3. SWOT Analysis.

List of Table

Table 01: Global Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 02: Global Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 03: Global Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 04: Global Antithrombin Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 06: North America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 07: North America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 08: North America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 09: Europe Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 10: Europe Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 11: Europe Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 12: Europe Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 13: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 14: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 15: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 16: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 17: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 18: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 19: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 20: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 21: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 22: Middle East & Africa Size (US$ Mn) Forecast, by Source, 2017–2027

Table 23: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

List of Figure

Figure 01: Global Antithrombin Market Size (US$ Mn) Forecast, 2017–2027

Figure 02: Market Value Share, by Region 2018

Figure 03: Market Value Share, by Application 2018

Figure 04: Market Value Share, by Source 2018

Figure 05: Market Value Share, by Dosage Form 2018

Figure 06: Global Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 07: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017–2027

Figure 08: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research, 2017–2027

Figure 09: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017–2027

Figure 10: Global Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 11: Global Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 12: Global Antithrombin Market Revenue (US$ Mn), by Human Source, 2017–2027

Figure 13: Global Antithrombin Market Revenue (US$ Mn), by Goat Milk Source, 2017–2027

Figure 14: Global Antithrombin Market Revenue (US$ Mn), by Others, 2017–2027

Figure 15: Global Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 16: Global Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 17: Global Antithrombin Market Revenue (US$ Mn), by Lyophilized Dosage Form, 2017–2027

Figure 18: Global Antithrombin Market Revenue (US$ Mn), by Liquid Dosage Form, 2017–2027

Figure 19: Global Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 20: Global Antithrombin Market Value Share Analysis, by Region, 2018 and 2027

Figure 21: Global Antithrombin Market Attractiveness Analysis, by Region, 2017–2027

Figure 22: North America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 23: North America Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 24: North America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 25: North America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 26: North America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 27: North America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 28: North America Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 29: North America Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 30:North America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 31: Europe Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 32: Europe Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 33: Europe Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 34: Europe Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 35: Europe Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 36: Europe Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 37: Europe Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 38: Europe Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 39: Europe Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 40: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 41: Asia Pacific Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 42: Asia Pacific Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 43: Asia Pacific Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 44: Asia Pacific Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 45: Asia Pacific Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 46: Asia Pacific Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 47: Asia Pacific Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 48:Asia Pacific Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 49: Latin America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 50: Latin America Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 51: Latin America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 52: Latin America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 53: Latin America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 54: Latin America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 55: Latin America Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 56: Latin America Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 57: Latin America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 58: Middle East & Africa Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 59: Middle East & Africa Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 60: Middle East & Africa Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 61: Rest of the World Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 62: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 63: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 64: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 65: Heat Map Analysis By Company 2018

Figure 66: Revenue for the LFB Group (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 67: Breakdown of Net Sales, by Business Segment, 2018

Figure 68: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 69: Breakdown of Net Sales, by Business Segment, 2018

Figure 70: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018

Figure 71: Breakdown of Net Sales, by Region, 2018

Figure 72: CSL Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 73: Breakdown of Net Sales by Business segments, 2018

Figure 74: Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Antithrombin Market Forecast, 2019-2027

Schedule a Call